Advertisements



Outlook expects first results from Phase 3 program for ONS-5010 in six months

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 14th, 2020

Corvus Gold receives results from Main Zone infill, step-out Phase-4 program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2020

Incyte announces results from Phase 3 TRuE-AD program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2020

Foamix announces efficacy results from FMX103 Phase 3 program for rosacea

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 18th, 2020

Replimune Group expects enrollment in Phase 2 RP1 trial to take 18-24 months

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 13th, 2020

Amcor reports first half results and improved outlook for fiscal 2020

ZURICH, Switzerland, Feb. 11, 2020 /PRNewswire/ -- Amcor (NYSE:AMCR, ASX: AMC)) today reported results for the six months ended December 31, 2019. First Half Fiscal 2020 Highlights(1) GAAP .....»»

Category: earningsSource: benzingaFeb 11th, 2020

Sol-Gel Technologies expects results from Phase 1 study of SGT-210 in 1H21

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 5th, 2020

Earnings Outlook: Netflix earnings should show fallout from new streaming rivals, preparations for more

Netflix Inc. endured the first wave of a competitive assault late last year, and financial results coming Tuesday will show how it was affected, and what it expects as it braces for a second wave in the spring......»»

Category: topSource: marketwatchJan 17th, 2020

Chiasma expects top-line results from MPOWERED Phase 3 trial in 4Q20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 10th, 2020

Otonomy expects results from Phase 1/2 OTO-413 trial in 2H20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Otonomy expects results from Phase 1/2 OTO-313 trial in 2Q20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Otonomy expects results from Phase 3 OTIVIDEX trial in 3Q20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Strongbridge expects to report results for Phase 3 LOGICS study in Q2 or Q3

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 9th, 2020

Molecular Templates expects interim results from Phase 1 MT-5111 study in Q2

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2020

Molecular Templates expects interim results from Phase 2 DLBCL study in 2020

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2020

Sol-Gel Technologies to discuss results from Twyneo Phase 3 Program

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 8th, 2020

Ovid Therapeutics expects results for Phase 2 ROCKET trial in early 2Q20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 7th, 2020

Nio"s stock has more than tripled in 3 months, boosted by better-than-expected results and upbeat outlook

Shares of Nio Inc. shot up 9.0% on heavy volum.....»»

Category: topSource: marketwatchDec 31st, 2019

Outlook Therapeutics expects topline results from NORSE 2 study in 1Q21

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2019

Outlook Therapeutics expects topline results from NORSE 1 study in 3Q20

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallDec 19th, 2019

Axsome expects topline results from MOMENTUM Phase 3 trial of AXS-07 in Q4

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 21st, 2019